Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Dexmedetomidine on Neurocognitive Function in Children with Retinoblastoma
NCT04700514Unknown
- Sponsor
- Seoul National University Hospital
- Start
- Feb 2021
- Primary completion
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of dexmedetomidine (2 arms), sponsored by Seoul National University Hospital. Primary endpoints: IQ score at 4 years and Developmental Test at 4 years. Status: unknown.
02
Drugs
dexmedetomidine
Beyond the preview
Go deeper on NCT04700514.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04700514.